Mueller AR - Search Results

1

The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A.

Mueller AR, Platz KP, Blumhardt G, Bechstein WO, Steinmüller T, Christe W, Hopf U, Lobeck H, Neuhaus P. Mueller AR, et al. Transplant Proc. 1995 Feb;27(1):1117-20. Transplant Proc. 1995. PMID: 7533359 Clinical Trial. No abstract available.

2

The effect of cyclosporine vs FK 506 on glucose metabolism.

Steinmueller T, Konrad T, Jonas S, Tullius S, Bechstein WO, Mueller A, Platz KP, Neumann U, Vicini P, Toffolo G, Cobelli C, Usadel KH, Neuhaus P. Steinmueller T, et al. Transplant Proc. 1999 Feb-Mar;31(1-2):1129-30. doi: 10.1016/s0041-1345(98)01932-0. Transplant Proc. 1999. PMID: 10083504 No abstract available.

3

The release of cytokines, adhesion molecules, and extracellular matrix parameters during and after reperfusion in human liver transplantation.

Mueller AR, Platz KP, Haak M, Undi H, Müller C, Köttgen E, Weidemann H, Neuhaus P. Mueller AR, et al. Transplantation. 1996 Oct 27;62(8):1118-26. doi: 10.1097/00007890-199610270-00017. Transplantation. 1996. PMID: 8900313

4

Immunosuppressive power and limitations of FK 506 for prevention and treatment of graft-vs-host disease after small bowel transplantation.

Platz KP, Mueller AR, Langrehr JM, Neuhaus P, Schraut WH. Platz KP, et al. Among authors: mueller ar. Transplant Proc. 1996 Oct;28(5):2523-4. Transplant Proc. 1996. PMID: 8907933 No abstract available.

5

Goals of small bowel preservation.

Mueller AR, Platz KP, Neuhaus P, Lee KK, Schraut WH. Mueller AR, et al. Transplant Proc. 1996 Oct;28(5):2633-5. Transplant Proc. 1996. PMID: 8907987 No abstract available.

6

Cytokine pattern during rejection and infection after liver transplantation--improvements in postoperative monitoring?

Platz KP, Mueller AR, Rossaint R, Steinmüller T, Lemmens HP, Lobeck H, Neuhaus P. Platz KP, et al. Among authors: mueller ar. Transplantation. 1996 Nov 27;62(10):1441-50. doi: 10.1097/00007890-199611270-00011. Transplantation. 1996. PMID: 8958270

7

Neurologic symptoms improve in patients with Wilson's disease despite immunosuppression.

Schumacher G, Mueller AR, Platz KP, Neuhaus R, Bechstein WO, Becker M, Luck W, Neuhaus P. Schumacher G, et al. Among authors: mueller ar. Transplant Proc. 1996 Dec;28(6):3099-100. Transplant Proc. 1996. PMID: 8962200 No abstract available.

8

BT563 significantly decreases sIL-2R plasma levels despite acute allograft rejection.

Mueller AR, Platz KP, Steinmüller T, Nüssler N, Neumann U, Gerlach H, Stoll C, Bechstein WO, Neuhaus P. Mueller AR, et al. Transplant Proc. 1996 Dec;28(6):3103-5. Transplant Proc. 1996. PMID: 8962203 No abstract available.

9

Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.

Platz KP, Tullius SG, Mueller AR, Schumacher G, Nüssler N, Neuhaus R, Bechstein WO, Lobeck H, Neuhaus P. Platz KP, et al. Among authors: mueller ar. Transplant Proc. 1996 Dec;28(6):3183-4. Transplant Proc. 1996. PMID: 8962235 No abstract available.

10

Hepatitis B recurrence in relation to immunosuppression and acute allograft rejection.

Platz KP, Mueller AR, Haller GW, Naumann U, Berg T, Fukomoto T, Lemmens HP, Hopf U, Lobeck H, Neuhaus P. Platz KP, et al. Among authors: mueller ar. Transplant Proc. 1996 Dec;28(6):3236-7. Transplant Proc. 1996. PMID: 8962252 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page